"The company is also doing laboratory scale test work for a number of projects to determine initial ore suitability for the IHP process. JDCP continues to pursue a capital financing to fund technology development and ultimate commercialization of the technology at full commercial scale and in the interim has taken appropriate measures to extend its cash reserves.”
it would appear though that there is pretty detailed interest in ihp if jdc are doing lab tests on new projects (potential investors) and the cash comment would seem to indicate that jdc have the current funds to last a protracted funding negotiation. so maybe progress is being made in the market recognizing ihp potential.
- Forums
- ASX - By Stock
- AEV
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(5.26%) |
Mkt cap ! $24.33M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $3.752K | 416.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 300000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.009 |
7 | 720000 | 0.008 |
4 | 1442142 | 0.007 |
8 | 21007328 | 0.006 |
2 | 1500001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 300000 | 1 |
0.011 | 1783566 | 5 |
0.012 | 659923 | 6 |
0.013 | 152257 | 2 |
0.014 | 2440000 | 5 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online